Where can researchers source third-party tested Melanotan I?

Midwest Peptide supplies research-grade Melanotan I with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Melanotan I Wound Healing Research | Midwest Peptide

Melanotan II Neuroprotection: MC4R in CNS Injury ModelsPrev|Melanotan I Anti-Inflammatory Research: MC1R Immune EffectsNext

Melanotan I Wound Healing Research: Dermal Repair Studies

Q: Is Melanotan I approved for human use?

No. Melanotan I is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Melanotan I · Published April 24, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Melanotan I wound healing research examines MC1R-mediated dermal repair biology in rodent skin injury models. Studies measure wound closure, fibroblast activity, anti-inflammatory cytokine modulation, and dermal repair biomarkers across standardized wound healing research protocols using this MC1R-selective peptide. For research use only, not for human consumption.

Melanotan I Wound Healing Research: Dermal Repair Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

MC1R in Skin Biology Beyond Melanocytes
Inflammatory Phase Modulation
Re-Epithelialization Research
Fibroblast and Matrix Biology
Angiogenesis in Wound Healing
Scar Quality Research
Diabetic Wound Healing
Photoprotection and Wound Healing Integration
Research Design for Wound Healing Studies
Research Peptide Referenced
Related Research Reading
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Melanotan I wound healing research extends the Melanotan I research cluster into the dermal repair biology that intersects with the pigmentation and photoprotection pharmacology documented across the cluster. MC1R signaling affects multiple aspects of wound healing including inflammation modulation, fibroblast activity, angiogenesis, and the coordinated repair response to dermal injury in rodent models.

Frequently Asked Questions

What is Melanotan I in research contexts?

Melanotan I (afamelanotide) is a synthetic 13-amino-acid analog of alpha-melanocyte-stimulating hormone (alpha-MSH) with high MC1R selectivity. It is studied in preclinical research and clinical literature for melanogenesis, photoprotection, and erythropoietic protoporphyria.

How does MC1R signaling support wound healing?

MC1R is expressed on fibroblasts, keratinocytes, and immune cells in the wound microenvironment. Activation supports re-epithelialization, modulates inflammatory cytokine profiles, and may enhance collagen organization in healed tissue based on rodent dermal repair research.

What dermal repair endpoints are measured with Melanotan I?

Endpoints include wound closure rate, re-epithelialization on histology, granulation tissue formation, collagen deposition, inflammatory cell profiles, and biomechanical strength of healed tissue at terminal sacrifice in rodent models.

Is Melanotan I approved for human use?

Glossary

Key terms used in this article.

MC1R: Melanocortin 1 receptor, the primary GPCR on melanocytes that signals melanin synthesis upon alpha-MSH binding.
Melanogenesis: The biochemical pathway producing melanin from tyrosine within melanosomes of melanocytes.
Eumelanin: The dark brown to black melanin pigment that provides photoprotective absorbance of UV radiation.
Tyrosinase: The rate-limiting copper-dependent enzyme catalyzing the first two steps of melanin biosynthesis from tyrosine.
Erythropoietic Protoporphyria (EPP): A rare genetic disorder of heme biosynthesis causing severe photosensitivity, the indication for clinical afamelanotide use.
Re-Epithelialization: The process by which the wound surface is covered by new keratinocytes during healing.
Wound Microenvironment: The complex local milieu of cells, ECM, growth factors, and cytokines that orchestrates wound healing.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Melanotan I is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.

MC1R in Skin Biology Beyond Melanocytes

The MC1R receptor is expressed in multiple skin cell types beyond melanocytes including keratinocytes, dermal fibroblasts, and the resident immune cells in the dermis. This broader expression pattern provides the anatomical basis for MC1R effects on wound healing that extend beyond the pigmentation biology that is most prominently associated with the receptor.

Keratinocyte MC1R signaling affects proliferation, migration, and barrier function, all of which are relevant to the re-epithelialization phase of wound healing. Dermal fibroblast MC1R signaling affects extracellular matrix production and matrix remodeling during the proliferative and remodeling phases. Immune cell MC1R signaling modulates the inflammatory response to injury as documented in the anti-inflammatory article in this cluster.

The Nature subject hub on wound healing and the ScienceDirect skin repair topic page archive primary research on the integrated biology of dermal repair.

Inflammatory Phase Modulation

The initial inflammatory phase of wound healing involves recruitment of neutrophils and macrophages to the injury site, production of pro-inflammatory cytokines, and clearance of damaged tissue and microbial contamination. The inflammatory phase must be well regulated. Excessive or prolonged inflammation impairs the transition to the proliferative phase. Inadequate inflammation fails to clear the wound bed and allows persistent colonization or tissue debris.

Published Melanotan I wound healing research documents modulation of the inflammatory phase toward optimal regulation. Pro-inflammatory cytokine levels are reduced compared to untreated controls but are not abolished. Inflammatory cell infiltration occurs appropriately but resolves more rapidly in treated animals. The shift toward controlled inflammation supports the transition to the proliferative phase and ultimately improves the healing outcome.

The inflammatory modulation in wound healing extends the broader anti-inflammatory effects documented in the companion anti-inflammatory article. The wound healing context provides a specific research application for the immune modulatory properties of MC1R selective agonism.

Re-Epithelialization Research

Re-epithelialization is the closure of the wound epithelium through keratinocyte proliferation and migration from the wound edges. Published Melanotan I research documents enhanced re-epithelialization rates in treated rodent wounds compared to untreated controls. The effect reflects MC1R mediated effects on keratinocyte biology including modulation of migration capacity and support of proliferative activity.

Keratinocyte migration assays in cell culture systems have documented the direct effects of MC1R activation on migration rates. The in vivo re-epithelialization findings translate these cellular level effects into tissue level outcomes. The combined data supports the interpretation that MC1R signaling supports the epithelial components of wound healing alongside the inflammatory and matrix components.

The Cell Press journal Developmental Cell archives primary research on keratinocyte biology in wound healing.

Fibroblast and Matrix Biology

The proliferative phase of wound healing involves fibroblast recruitment and activation, production of extracellular matrix including collagen, and formation of granulation tissue that provides the structural foundation for the repaired tissue. Published Melanotan I research on dermal fibroblast biology documents effects on proliferation, matrix production, and matrix remodeling enzyme expression.

The fibroblast effects connect to the broader extracellular matrix research documented for other peptides in adjacent clusters. The GHK-Cu collagen synthesis article covers copper peptide effects on fibroblast matrix production. The BPC-157 tendon and ligament article covers BPC-157 effects on connective tissue repair. Melanotan I contributes to the matrix biology through MC1R signaling that is distinct from the mechanisms of these other peptides.

The combined multi-peptide research landscape provides researchers with multiple pharmacological entry points into wound healing biology. Each compound offers a different mechanistic approach, and comparative or combination research can characterize how different receptor systems contribute to the integrated repair response.

Angiogenesis in Wound Healing

Angiogenesis is critical for wound healing because the new granulation tissue requires vascular supply to support the metabolic demands of the proliferative phase. Published Melanotan I research on wound healing documents increased microvessel density in the granulation tissue of treated wounds compared to untreated controls.

The angiogenic effects reflect MC1R signaling on endothelial cells and on the supporting cells that regulate vascular formation. The magnitude of angiogenic enhancement is modest compared to what is produced by dedicated angiogenic factors but is reproducible across published research and contributes to the integrated wound healing improvement.

The angiogenic findings connect to the BPC-157 angiogenesis article which covers VEGF pathway upregulation in wound healing, and to the KLOW angiogenesis article which covers angiogenesis in multi-peptide blend research. Different compounds contribute to angiogenic biology through different mechanisms.

Scar Quality Research

Beyond the acceleration of wound closure, scar quality is an important endpoint in wound healing research. Published Melanotan I research has examined scar outcomes including collagen organization, mechanical strength of the healed tissue, and pigmentation of the scar tissue.

The findings document improved collagen organization with more normal fiber alignment in treated wounds compared to untreated controls. The improved collagen organization translates to better mechanical strength and more favorable morphological outcomes. Scar pigmentation is also affected, with more normal pigmentation in treated animals compared to the hypo or hyperpigmentation that can accompany untreated wound healing.

The scar quality findings connect to the GLOW scar remodeling article which covers scar quality research in the multi-peptide blend context. The GHK-Cu wound healing article covers the copper peptide scar quality findings.

The Wiley Online Library dermatology collection and the Frontiers in Physiology open access journal archive primary research on scar quality biology.

Diabetic Wound Healing

Diabetic wound healing impairment is a research context where multiple pharmacological approaches have been examined. The impaired healing in diabetic models involves reduced angiogenesis, altered inflammatory tone, impaired fibroblast function, and the broader metabolic dysregulation of the diabetic state. Published Melanotan I research in diabetic wound healing models documents partial restoration of the normal healing response.

The diabetic wound healing findings integrate with the incretin receptor agonist research documented in the GLP-1 SM cluster and the GLP-2 TZ cluster. The metabolic improvements from incretin agonists reduce the diabetic background that impairs healing, while the direct wound healing support from MC1R agonists addresses the tissue level repair biology. Combination approaches that engage both angles represent an emerging research direction.

Photoprotection and Wound Healing Integration

The photoprotection article covers the UV damage protective effects. Photoaged skin has impaired healing capacity, and the photoprotective effects of Melanotan I may preserve the healing capacity that would otherwise decline with chronic UV exposure. This connection between photoprotection and healing provides another research application for MC1R selective agonism in dermatologic contexts.

The integration of photoprotection and wound healing extends the broader multi-effect profile of Melanotan I. A single receptor agonist produces coordinated effects across pigmentation, photoprotection, anti-inflammatory, and wound healing biology, all through MC1R signaling in different cell types. This multi-effect profile makes Melanotan I a distinctive research tool for dermatologic research.

Research Design for Wound Healing Studies

Wound healing research uses several standardized models including excisional wound models, incisional wound models, and thermal burn models. Each provides different information. Excisional models test the full healing response including re-epithelialization. Incisional models test matrix reorganization. Burn models add a thermal injury component with distinctive inflammatory biology.

Topical and systemic administration have both been used in Melanotan I wound healing research. Topical application provides high local concentration at the wound site. Systemic administration provides distributed exposure that reaches the wound through the circulation. Both approaches have shown wound healing benefits in published research, with topical application typically producing larger effects at early time points and systemic administration supporting sustained effects throughout the healing process.

Research Peptide Referenced

MT-1 10mg, research grade Melanotan I, MC1R selective, third party COA

For complete sourcing details see the Melanotan I sourcing guide.

Within the MT-1 cluster:

Related clusters:

Not for human consumption. Research use only.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

GLOW 70mg, 99%+ purity, COA included
MT-1 10mg, 99%+ purity, COA included
MT-2 10mg, 99%+ purity, COA included
GLP-1 SM 20mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Melanotan I Wound Healing Research: Dermal Repair Studies

Frequently Asked Questions

What is Melanotan I in research contexts?

How does MC1R signaling support wound healing?

What dermal repair endpoints are measured with Melanotan I?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

MC1R in Skin Biology Beyond Melanocytes

Inflammatory Phase Modulation

Re-Epithelialization Research

Fibroblast and Matrix Biology

Angiogenesis in Wound Healing

Scar Quality Research

Diabetic Wound Healing

Photoprotection and Wound Healing Integration

Research Design for Wound Healing Studies

Research Peptide Referenced

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Melanotan I Wound Healing Research: Dermal Repair Studies

Frequently Asked Questions

What is Melanotan I in research contexts?

How does MC1R signaling support wound healing?

What dermal repair endpoints are measured with Melanotan I?

Is Melanotan I approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

MC1R in Skin Biology Beyond Melanocytes

Inflammatory Phase Modulation

Re-Epithelialization Research

Fibroblast and Matrix Biology

Angiogenesis in Wound Healing

Scar Quality Research

Diabetic Wound Healing

Photoprotection and Wound Healing Integration

Research Design for Wound Healing Studies

Research Peptide Referenced

Related Research Reading

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan I?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?